SQZ Biotechnologies Gross Profit 2020-2023 | SQZ
SQZ Biotechnologies gross profit from 2020 to 2023. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
SQZ Biotechnologies Annual Gross Profit
(Millions of US $) |
| 2022 |
$21 |
| 2021 |
$27 |
| 2020 |
$21 |
| 2019 |
$20 |
SQZ Biotechnologies Quarterly Gross Profit
(Millions of US $) |
| 2023-03-31 |
|
| 2022-12-31 |
$12 |
| 2022-09-30 |
$3 |
| 2022-06-30 |
$3 |
| 2022-03-31 |
$3 |
| 2021-12-31 |
$12 |
| 2021-09-30 |
$5 |
| 2021-06-30 |
$5 |
| 2021-03-31 |
$5 |
| 2020-12-31 |
$2 |
| 2020-09-30 |
$6 |
| 2020-06-30 |
$6 |
| 2020-03-31 |
$6 |
| 2019-12-31 |
|
| 2019-09-30 |
$4 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.018B |
$0.021B |
|
SQZ Biotechnologies Company is a clinical-stage biotechnology company. It develops transformative cell therapies for patients with cancer, infectious diseases and other serious conditions. The company's prime product candidate consist SQZ-PBMC-HPV which is in clinical stage. SQZ Biotechnologies Company is based In Watertown, Massachusetts.
|
